Oncology
Oncology

Patients Selection for Abemaciclib

By :
Dr. Alistair Ring
Oncology

CDK46i Trials Overview in Breast Cancer

By :
Prof. Stephen Johnston
Oncology

Case Discussion: Endocrine-Sensitive MBC

By :
Prof. Sherko Kümmel
Oncology

MONARCH 2 Trial - Clinical Impact on Clinical Practice

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

Delay of Chemotherapy in Patients Receiving Abemaciclib + Fulvestrant

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

MONARCH 2 Trial - Patient Characteristics and OS Results

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

Safety and Tolerability of Abemaciclib & Patient Counseling

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

MONARCH 2 Trial - Maturity of OS Results

By :
Dr. Meteb Al Foheidi / Dr. Mark Verrill
Oncology

Patient selection for Abemaciclib

By :
Prof. Alistair Ring